ongoing monitoring for complications

Last reviewed 01/2018

ongoing monitoring for complications

The main dangers once treatment has started are

  • cerebral oedema
    • look for sign and symptoms suggestive of cerebral oedema
      • headache & slowing of heart rate
      • change in neurological status (restlessness, irritability, increased drowsiness, incontinence)
      • specific neurological signs (eg. cranial nerve palsies)
      • rising BP, decreased O2 saturation
      • abnormal posturing
      • dramatic changes such as convulsions, papilloedema, respiratory arrest are late signs
      • associated with extremely poor prognosis
    • if cerebral oedema is suspected inform senior staff immediately and arrange transfer to PICU
      • exclude hypoglycaemia as a possible cause of any behaviour change
      • give hypertonic (2.7%) saline (5mls/kg over 5-10 mins) or Mannitol 0.5 - 1.0 g/kg stat (= 2.5 - 5 ml/kg Mannitol 20% over 20 minutes). This needs to be given as soon as possible if warning signs occur (eg headache or pulse slowing).
      • restrict IV fluids to 1/2 maintenance and replace deficit over 72 rather than 48 hours
      • discuss with PICU consultant. Do not intubate and ventilate until an experienced doctor is available
      • once the child is stable, exclude other diagnoses by CT scan - other intracerebral events may occur (thrombosis, haemorrhage or infarction) and present similarly
      • a repeated dose of Mannitol may be required after 2 hours if no response
      • document all events (with dates and times) very carefully in medical records
  • hypoglycaemia &hypokalaemia
    • avoid by careful monitoring and adjustment of infusion rates
    • consideration should be given to adding more glucose if BG falling quickly even if still above 4 mmol/l (1).

Serum urea and electrolytes should be repeated two hours after starting treatment and thereafter as required; the blood glucose should be measured every two hours. Regular blood gas analysis can give a good indicator of improvement.

Reference: